Amesite (AMST) Cash & Equivalents (2019 - 2026)

Amesite (AMST) has 8 years of Cash & Equivalents data on file, last reported at $640711.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 77.59% year-over-year to $640711.0; the trailing twelve-month figure through Mar 2026 stood at $640711.0 (down 77.59% YoY), and the FY2025 full-year result was $2.3 million, up 12.67% from the prior year.
• Cash & Equivalents eased to $640711.0 in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $8.9 million in Q1 2022 to a low of $519706.0 in Q4 2024.
• A 5-year average of $3.9 million and a median of $3.0 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents plunged 85.81% in 2024 and soared 124.24% in 2025, its largest moves.
• Tracing AMST's Cash & Equivalents over 5 years: stood at $7.0 million in 2022, then sank by 47.6% to $3.7 million in 2023, then sank by 85.81% to $519706.0 in 2024, then jumped by 124.24% to $1.2 million in 2025, then slumped by 45.02% to $640711.0 in 2026.
• Business Quant data shows AMST's Cash & Equivalents at $640711.0 in Q1 2026, $1.2 million in Q4 2025, and $1.8 million in Q3 2025.